Hope for Parkinson’s disease symptoms is found in late-stage drug study
Tavapadon, a drug being tested to treat early Parkinson's disease, has shown great promise in a Phase III trial by AbbVie, ...
Late-stage breast cancer is rising, especially among Black women: Study
Black women experience advanced diagnoses 55% more often than white women and are more likely to die from the disease, the ...
Late-stage breast cancer diagnoses increase dramatically in U.S.
The number of U.S. women with breast cancer that has spread elsewhere in the body by the time of diagnosis increased ...
AbbVie's Parkinson's disease drug meets main goal in late-stage study
AbbVie's experimental drug to treat early Parkinson's disease met the main goal in a late-stage study, the drugmaker said on ...
More Women Are Being Diagnosed With Breast Cancer at Later Stages
TUESDAY, Dec. 10, 2024 (HealthDay News) -- More breast cancers are being detected later in women, giving the tumors a chance ...
EurekAlert!3 天
Late-stage breast cancer diagnosis on the rise in US
The number of women with late-stage, invasive breast cancer at the time of diagnosis increased significantly among U.S. women ...
healthday2 天
Late-Stage Breast Cancer Diagnosis on the Rise in the U.S.
More women are hearing the words ‘late-stage, invasive breast cancer’ when they’re initially diagnosed, a new study finds.Late-stage breast cancer, which has me ...
ALZFORUM5 天
In Alzheimer’s Due to Down’s, Spatial Omics Spots Signs of Trouble
Strapped with an extra APP, people with Down’s syndrome are all but destined to develop Alzheimer’s dementia if they live ...
AbbVie's Early Parkinson's Candidate Hits Primary Goal In Pivotal Late-Stage Study
AbbVie reports Phase 3 TEMPO-2 trial success for tavapadon, a once-daily Parkinson's treatment, showing significant symptom ...
New test uses AI to detect breast cancer at earliest stage yet
The new test works by shining a laser beam into the patient's blood plasma, then using AI to interpret the results - with ...
AbbVie's Tavapadon Hits Key Goals in Third Phase 3 Parkinson's Study -- Update
AbbVie picked up tavapadon as part of its $8.7 billion acquisition of Cerevel Therapeutics earlier this year. Prior to the deal closing, Cerevel had reported a successful Phase 3 study of tavapadon as ...